Larger studies are required to determine the frequency of clonal hematopoiesis in CML and to unravel the significance of mutants that pre-exist the acquisition of BCR::ABL1. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.